Following the U.S. government's substantial investment in the quantum computing industry, traders have flocked to the options market for IBM. Data from Cboe LiveVol indicates that trading volume for IBM (IBM.US) options approached 200,000 contracts, approximately 15 times the average daily volume over the past 30 days. Call option volume was nearly eight times that of put options, with over 42,000 calls bought versus 27,500 calls sold. Fewer than 4,000 puts were purchased, resulting in an extremely low Put/Call Ratio of 0.14, reflecting a highly bullish market sentiment.
Event Background: $2 Billion Quantum Initiative, IBM Secures Half On May 21, 2026, the U.S. Department of Commerce announced a significant decision poised to impact the global quantum computing industry: providing a total of $2.013 billion in federal incentive funds to nine quantum computing companies. The agreements include provisions for the U.S. government to acquire equity, marking a strategic shift from past basic research funding to deep industrial involvement through "equity-for-funding."
IBM emerges as the primary beneficiary of this initiative. The company is set to receive $1 billion to establish a new entity named "Anderon," dedicated to manufacturing quantum computing chips. The new facility will be located in New Albany, New York, and will be the nation's first factory focused on quantum chip production. IBM subsequently confirmed its collaboration with the U.S. government to build the country's first "dedicated quantum wafer foundry," supported by the proposed $1 billion government grant.
Beyond IBM, chip foundry GlobalFoundries (GFS.US) will receive $375 million to construct a factory producing components for various quantum devices. Concurrently, several quantum companies pursuing different technological paths, including publicly traded firms like D-Wave Quantum, Rigetti Computing, and Infleqtion, will also receive funding.
Notably, this funding is not an isolated event but part of a series of recent U.S. strategic deployments in high-tech industries. The CHIPS and Science Act passed in 2022 already allocated over $52 billion in subsidies and incentives for the semiconductor sector. Under this framework, Intel previously received $7.86 billion in direct grants, and the U.S. government converted $8.9 billion in CHIPS Act funding into approximately 433.3 million Intel shares, acquiring a roughly 10% stake. The paper profit on this investment now exceeds $30 billion. Quantum computing is now following a similar policy trajectory.
Options Market Anomaly: Trading Logic Behind Extreme Data Following the positive news, options traders surged into IBM contracts, sparking an unusual trading frenzy. According to Cboe LiveVol data, IBM options volume neared 200,000 contracts, 15 times the 30-day average daily volume. Call volume was nearly eight times put volume, with over 42,000 calls bought versus 27,500 calls sold. Fewer than 4,000 puts were purchased, driving the Put/Call Ratio down to an extremely bullish 0.14.
Activity in the options market far exceeded normal levels. On May 21, IBM's stock trading volume reached 8,684,621 shares, compared to an average volume of 5,978,263 shares, with a turnover rate of 2.69% and a trading value of $6.159 billion. Implied volatility surged nearly 4 points to 36.55%, indicating a sharp increase in market pricing for future volatility.
A particularly notable trade was an unusually long-term bullish bet. A trader spent $2.7 million to purchase over 500 call option contracts with a strike price of $260, expiring on December 15, 2028. These are currently the longest-dated tradable IBM options and carry a significant premium. This implies the trader essentially needs IBM's stock price to exceed $312 by expiration, or rise about 30% from current levels, for the position to reach a substantive profit zone. Such long-dated option trades are rare in the tech sector, suggesting some professional investors view the government grant as a catalyst for IBM's stock price appreciation over several years, rather than short-term sentiment-driven speculation.
Stock Price History: Key Junctures Amid Multiple Bull and Bear Cycles IBM's stock price has experienced a roller-coaster ride in recent years. While it has risen 500% from last year's low, this gain follows a significant prior downturn. Previously, IBM enjoyed a multi-year bull run driven by its strategic pivot to cloud and hybrid services. However, starting last November, the stock fell 30%, influenced by a broader sell-off in cloud-related businesses.
Looking back to October 2025, IBM's Q3 earnings report showed total revenue of $16.33 billion and adjusted EPS of $2.65, beating analyst expectations of $16.09 billion. Despite this, slowing growth in the key cloud software segment led to a more than 6% drop in after-hours trading. The company's full-year constant currency revenue growth guidance was revised down to over 5%, a noticeable deceleration from the 7% growth rate that quarter. Subsequent months of decline pulled IBM's stock price back down.
The quantum computing industry policy news on May 21 reignited significant bullish market enthusiasm.
Fundamentals: Convergence of Policy Catalyst and Industry Transformation The market's strong reaction to this government funding stems from IBM's quantum computing roadmap entering a critical validation phase. At the CES exhibition in early 2026, IBM explicitly stated that "2026 will be a turning point for quantum advantage" and anticipated "strong quantum advantage statements" this year. IBM CEO Arvind Krishna noted on the Q1 earnings call that quantum systems are beginning to surpass traditional supercomputers in specific tasks, with early signs expected this year.
In May, IBM unveiled its most advanced quantum processor to date, "Quantum Nighthawk," designed specifically for high-performance quantum software with the aim of achieving quantum advantage within 2026. Simultaneously, IBM introduced its "quantum-centric supercomputing" architecture, which deeply integrates CPUs, GPUs, and Quantum Processing Units (QPUs) into a unified computing system. The company also plans to prototype its error-correction decoder in 2026, paving the way for real-time error correction.
IBM has set clear technical milestones for quantum computing commercialization: achieving "quantum advantage" by 2026 and launching the world's first "fault-tolerant quantum computer" by 2029. The $1 billion government grant provides crucial funding to support this roadmap, particularly in overcoming the industrial bottleneck of scaling quantum chip manufacturing.
This quantum computing policy stimulus is not an isolated event but has triggered a systematic revaluation across the related sector. Share prices of relevant publicly traded companies rose on the news. Meanwhile, Intel is writing a textbook story of American corporate revival. After a five-year decline from a high of $69.29 in January 2020 to a low of $17.66 in April 2025, Intel's stock staged a dramatic reversal following a U.S. government investment agreement to acquire a 10% stake at $20.47 per share. Entering 2026, Intel's stock surged over 219% year-to-date, with the U.S. government's stake now valued at approximately $16 billion.
The U.S. government's support for IBM follows a remarkably similar narrative framework to its investment in Intel: both involve industry giants facing challenges in critical technology areas, receiving a revaluation opportunity through strategic government equity participation. Intel has successfully navigated this path, and the market is now betting on whether IBM can replicate the miracle.
Conclusion The current logic behind the IBM deal closely resembles Intel's prior recovery path, but there are fundamental differences. The core driver of Intel's revival is its catch-up in advanced process technology—its 18A process is expected to achieve mass production by 2027, with the U.S. government providing substantial manufacturing support. In contrast, IBM's quantum computing grant is a bet on a more distant, more disruptive, yet more uncertain technological frontier. While the commercialization of quantum computing is showing initial promise, true industrial-scale adoption is still years away.
Options market data reveals a clear divergence between short-term traders and long-term investors. Short-term capital concentrated on call options with strike prices of $240 and $245 expiring on May 22, betting on an immediate pulse effect from the news. In contrast, the $2.7 million deep out-of-the-money call position expiring in 2028 requires the stock to rise over 30% within two and a half years to become profitable, indicating a deep, long-term bet by some institutional funds on IBM's transformation.
As quantum computing approaches the historical juncture of moving from the laboratory to industrialization, this deal for IBM may signify more than just a turning point for one company. It potentially marks the entry of global quantum computing competition into a new phase—shifting from a technological race to industrial implementation, and escalating from corporate competition to national strategy. For investors, aligning the timeline for technological realization with valuation will be a central theme for the years ahead.
